Posts in tag

Wegovy


Supplies of Ozempic (semaglutide) should be prioritised for type 2 diabetes patients the TGA says, as sponsor Novo Nordisk, launches its Wegovy brand for weight loss  Pharmacists and prescribers are …

Pharmacists are being warned that they could be liable for any adverse outcome patients experience should they supply compounded semaglutide-like products  Reports that a telehealth provider plans to make compounded …

Eli Lilly’s Trulicity had been been ‘go-to’ replacement for in-demand Ozempic Trulicity, the type-2 diabetes preparation which had been a regular stop-gap option when the much-hyped Ozempic was in short …

Potential blockbuster dubbed Zepbound to join cousin drug Mounjaro on US market Tirzepatide, Eli Lilly’s GIP and GLP-1 agonist, described by media as “the King Kong of drugs”, has been …

Whether health industry or junk food business, steamroller popularity of weight loss drug shakes up stock prices The huge success of the new wave of GLP-1 (glucagon-like peptide-1) receptor agonist …

Eli Lilly’s Mounjaro would need “substantial price reduction”, says PBAC Mounjaro, the type-2 diabetes medication that the New York Times recently predicted “’could overshadow Ozempic” has been refused funding via …

Concerns Ozempic ingredient may be related to thyroid cancer and suicide ideation draws attention of EMA Semaglutide, the active ingredient in hyped diabetes and weight loss drug, Ozempic and others, …

Ozempic/Wegovy sponsor trumpets results of Phase III clinical trial as its halts US ads A trial of an oral version of Novo Nordisk’s obesity and diabetes medication semaglutide, the active …

Will Eli Lilly’s potential blockbuster get the same social media weight-loss attention as shortage plagued Ozempic? The next generation of Type-2 diabetes drugs – and by extension weight-loss drugs – …

Wild card billionaire puts new, trim look down to fasting and taking semaglutide prep Wegovy Mercurial South African billionaire Elon Musk has sent social media into a minor swirl again …